175 related articles for article (PubMed ID: 20467687)
1. PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches.
Hung LH; Teh SY; Jester J; Lee AP
Lab Chip; 2010 Jul; 10(14):1820-5. PubMed ID: 20467687
[TBL] [Abstract][Full Text] [Related]
2. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of continuous flow nanosphere formation by controlled microfluidic transport.
Laulicht B; Cheifetz P; Mathiowitz E; Tripathi A
Langmuir; 2008 Sep; 24(17):9717-26. PubMed ID: 18681411
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres.
Liu X; Kaminski MD; Chen H; Torno M; Taylor L; Rosengart AJ
J Control Release; 2007 May; 119(1):52-8. PubMed ID: 17350131
[TBL] [Abstract][Full Text] [Related]
6. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T
Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534
[TBL] [Abstract][Full Text] [Related]
7. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
9. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D
Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100
[TBL] [Abstract][Full Text] [Related]
10. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Budhian A; Siegel SJ; Winey KI
Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
[TBL] [Abstract][Full Text] [Related]
12. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
[TBL] [Abstract][Full Text] [Related]
14. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
15. Effects of chemical and physical parameters in the generation of microspheres by hydrodynamic flow focusing.
Schneider T; Chapman GH; Häfeli UO
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):361-8. PubMed ID: 21680160
[TBL] [Abstract][Full Text] [Related]
16. A novel preparation method for PLGA microspheres using non-halogenated solvents.
Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
[TBL] [Abstract][Full Text] [Related]
17. Solvent effects on the microstructure and properties of 75/25 poly(D,L-lactide-co-glycolide) tissue scaffolds.
Sander EA; Alb AM; Nauman EA; Reed WF; Dee KC
J Biomed Mater Res A; 2004 Sep; 70(3):506-13. PubMed ID: 15293325
[TBL] [Abstract][Full Text] [Related]
18. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres.
Martinez B; Lairion F; Pena MB; Di Rocco P; Nacucchio MC
J Microencapsul; 1997; 14(2):155-61. PubMed ID: 9132467
[TBL] [Abstract][Full Text] [Related]
19. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
20. Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery.
Vukomanović M; Skapin SD; Jančar B; Maksin T; Ignjatović N; Uskoković V; Uskoković D
Colloids Surf B Biointerfaces; 2011 Feb; 82(2):404-13. PubMed ID: 20951005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
